Smith & Nephew plc (SNN) Income Statement

NYSE: SNNRevenue, profits, margins and EPS over 10 years.

SNN 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+6.1%
$6.16B
2025 · hover or tap a bar for each year
2016: $4.67B (+0.8%)2017: $4.76B (+2.1%)2018: $4.90B (+2.9%)2019: $5.14B (+4.8%)2020: $4.56B (−11.2%)2021: $5.21B (+14.3%)2022: $5.21B (+0.1%)2023: $5.55B (+6.4%)2024: $5.81B (+4.7%)2025: $6.16B (+6.1%)
20162025
Gross profit+3.1%
$4.21B
2025 · hover or tap a bar for each year
2016: $3.40B (−2.7%)2017: $3.52B (+3.5%)2018: $3.61B (+2.5%)2019: $3.81B (+5.6%)2020: $3.18B (−16.5%)2021: $3.70B (+16.3%)2022: $3.70B (+0.1%)2023: $3.90B (+5.3%)2024: $4.08B (+4.7%)2025: $4.21B (+3.1%)
20162025
Operating income+20.9%
$794.0M
2025 · hover or tap a bar for each year
2016: $801.0M (+27.5%)2017: $934.0M (+16.6%)2018: $863.0M (−7.6%)2019: $815.0M (−5.6%)2020: $295.0M (−63.8%)2021: $593.0M (+101.0%)2022: $450.0M (−24.1%)2023: $425.0M (−5.6%)2024: $657.0M (+54.6%)2025: $794.0M (+20.9%)
20162025
Net income+51.7%
$625.0M
2025 · hover or tap a bar for each year
2016: $784.0M (+91.2%)2017: $767.0M (−2.2%)2018: $663.0M (−13.6%)2019: $600.0M (−9.5%)2020: $448.0M (−25.3%)2021: $524.0M (+17.0%)2022: $223.0M (−57.4%)2023: $263.0M (+17.9%)2024: $412.0M (+56.7%)2025: $625.0M (+51.7%)
20162025
EPS (diluted)−28.3%
$0.71
2025 · hover or tap a bar for each year
2016: $1.32 (−41.6%)2017: $1.35 (+2.3%)2018: $2.63 (+94.8%)2019: $4.03 (+53.2%)2020: $1.02 (−74.7%)2021: $1.26 (+23.5%)2022: $0.25 (−80.2%)2023: $1.66 (+564.0%)2024: $0.99 (−40.4%)2025: $0.71 (−28.3%)
20162025
Net profit margin+3.0 pts
10.1%
2025 · hover or tap a point for each year
2016: 16.8% (+7.9 pts)2017: 16.1% (−0.7 pts)2018: 13.5% (−2.6 pts)2019: 11.7% (−1.8 pts)2020: 9.8% (−1.9 pts)2021: 10.1% (+0.2 pts)2022: 4.3% (−5.8 pts)2023: 4.7% (+0.5 pts)2024: 7.1% (+2.4 pts)2025: 10.1% (+3.0 pts)
20162025

SNN revenue and net income

RevenueNet incomeNet margin (right axis)

Where SNN's revenue goes

2025
Revenue
$6.16B100.0%
Cost of revenue
−$1.96B−31.7%
Gross profit
$4.21B68.3%
Research & development
−$346.0M−5.6%
Sales, general & admin
−$2.79B−45.3%
Other operating expenses
−$277.0M−4.5%
Operating income
$794.0M12.9%
Interest & other expense
−$15.0M−0.2%
Income taxes
−$154.0M−2.5%
Net income
$625.0M10.1%

Each bar shows an amount and its share of revenue. SNN kept 10.1% of revenue as net income.

SNN profit margins

GrossOperatingNet

SNN growth rates

to 2025
1 year3 years5 years10 years
Revenue+6.1%+5.7%+6.2%+2.9%
Gross profit+3.1%+4.4%+5.8%+1.9%
Operating income+20.9%+20.8%+21.9%+2.4%
Net income+51.7%+41.0%+6.9%+4.3%
EPS (diluted)−28.3%+41.6%−7.0%−10.9%

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

SNN quarterly EPS vs estimates

Reported EPSAnalyst estimate

Smith & Nephew beat the analyst EPS estimate in 3 of the last 8 quarters.

SNN income statement

Smith & Nephew plc annual income statement
2025202420232022202120202019201820172016
Revenue$6.16B$5.81B$5.55B$5.21B$5.21B$4.56B$5.14B$4.90B$4.76B$4.67B
Cost of revenue$1.96B$1.73B$1.65B$1.51B$1.51B$1.38B$1.33B$1.30B$1.25B$1.27B
Gross profit$4.21B$4.08B$3.90B$3.70B$3.70B$3.18B$3.81B$3.61B$3.52B$3.40B
Research & development$346.0M$343.0M$339.0M$345.0M$356.0M$307.0M$292.0M$246.0M$223.0M$230.0M
Sales, general & admin$2.79B$2.65B$2.60B$2.44B$2.39B$2.56B$2.31B$2.19B$2.15B$2.03B
Total operating expenses$3.41B$3.42B$3.47B$3.25B$3.10B$2.88B$2.99B$2.74B$2.58B$2.60B
Operating income$794.0M$657.0M$425.0M$450.0M$593.0M$295.0M$815.0M$863.0M$934.0M$801.0M
Interest income$28.0M$24.0M$34.0M$14.0M$6.0M$6.0M$43.0M$52.0M$37.0M$43.0M
Interest expense$141.3M$150.1M$132.5M$80.0M$80.0M$62.5M$65.3M$58.9M$57.6M$51.9M
Income before taxes$779.0M$498.0M$290.0M$235.0M$586.0M$246.0M$743.0M$781.0M$879.0M$1.06B
Income taxes$154.0M$86.0M$27.0M$12.0M$62.0M−$202.0M$143.0M$118.0M$112.0M$278.0M
Net income$625.0M$412.0M$263.0M$223.0M$524.0M$448.0M$600.0M$663.0M$767.0M$784.0M
EBITDA$1.45B$1.44B$1.27B$1.21B$1.27B$978.0M$1.48B$1.40B$1.31B$1.33B
EPS (diluted)$0.71$0.99$1.66$0.25$1.26$1.02$4.03$2.63$1.35$1.32
Gross margin68.3%70.2%70.2%70.9%71.0%69.7%74.1%73.5%73.8%72.8%
Operating margin12.9%11.3%7.7%8.6%11.4%6.5%15.9%17.6%19.6%17.2%
Net margin10.1%7.1%4.7%4.3%10.1%9.8%11.7%13.5%16.1%16.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SNN's financial statements (latest annual report filed March 16, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

SNN financial results

In fiscal year 2025 (ended December 31, 2025), Smith & Nephew reported revenue of $6.2 billion, up 6.1% from the year before. It had net income of $625.0 million (up 51.7%), a net profit margin of 10.1%. Diluted earnings per share came to $0.71. Over five years revenue grew at an average rate of 6.2% a year.

See the SNN stock overview for the latest quote and news, or the SNN chart for price history and technical indicators.

SNN income statement FAQ

What is Smith & Nephew's annual revenue?

Smith & Nephew reported total revenue of $6.2 billion for fiscal year 2025, which ended on December 31, 2025. That was up 6.1% from $5.8 billion the previous year.

Is Smith & Nephew profitable?

Yes. Smith & Nephew reported net income of $625.0 million in fiscal 2025, a net profit margin of 10.1%; its operating margin was 12.9%.

What is Smith & Nephew's gross margin?

Smith & Nephew's gross margin was 68.3% in fiscal 2025: for every $100 of revenue, Smith & Nephew kept $68 after the direct cost of its products and services.

How much does Smith & Nephew spend on research and development?

Smith & Nephew spent $346.0 million on research and development in fiscal 2025, 5.6% of revenue.

How fast is Smith & Nephew growing?

Revenue grew 6.2% a year on average over the last five fiscal years, from $4.6 billion to $6.2 billion.

What are Smith & Nephew's earnings per share?

Smith & Nephew earned $0.71 per diluted share in fiscal 2025, compared with $0.99 a year earlier.

When does Smith & Nephew's fiscal year end?

Smith & Nephew's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 16, 2026.

Medical Devices income statements